ICL (ICL) EVP Global IT discloses over 1.08M share stock options
Rhea-AI Filing Summary
ICL Group Ltd. executive Mishor Miriam, EVP Global IT, reported existing derivative holdings in a Form 3. The filing shows stock options giving rights to acquire 464,902 Ordinary Shares at an exercise price of $9.39 per share, expiring on February 8, 2027; these options are fully vested and exercisable and are held by a Trustee in the reporting person's name.
A second option position covers 620,177 Ordinary Shares at an exercise price of $5.87 per share, expiring on April 4, 2029, vesting in three equal annual installments from the April 4, 2024 grant date. The Form 3 records these as direct beneficial holdings and does not reflect new purchases or sales, but rather the baseline option positions as of the reporting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Mishor MIRIAM
Role
EVP, Global IT
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 1,085,079 shares (Direct)
Footnotes (5)
- F1. The stock options are fully vested and exercisable.
- F2. The stock options vest in three equal annual installments from the April 4, 2024, grant date.
- F3. Represents an exercise price of NIS 29.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
- F4. The options are held by a Trustee in the name of the Reporting Person.
- F5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.
Key Figures
Underlying shares (grant 1): 464,902 shares
Exercise price (grant 1): $9.39 per share
Underlying shares (grant 2): 620,177 shares
+3 more
6 metrics
Underlying shares (grant 1)
464,902 shares
Stock options over Ordinary Shares at $9.39 exercise price
Exercise price (grant 1)
$9.39 per share
Stock options expiring February 8, 2027
Underlying shares (grant 2)
620,177 shares
Stock options over Ordinary Shares at $5.87 exercise price
Exercise price (grant 2)
$5.87 per share
Stock options expiring April 4, 2029
Total underlying shares
1,085,079 shares
Sum of underlying Ordinary Shares across both option grants
Exchange rate used
$1.00 = NIS 3.149
Bank of Israel representative rate for exercise price conversion
Key Terms
Stock Options (Right to Buy), Ordinary Shares, exercise price, vest in three equal annual installments, +1 more
5 terms
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
exercise price financial
"Represents an exercise price of NIS 29.57, converted to U.S. dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in three equal annual installments financial
"The stock options vest in three equal annual installments from the April 4, 2024, grant date."
Trustee financial
"The options are held by a Trustee in the name of the Reporting Person."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the ICL Form 3 filing by Mishor Miriam report?
The Form 3 for ICL (ICL) reports Mishor Miriam’s existing stock option holdings. It lists two option grants over ICL Ordinary Shares, detailing exercise prices, expiration dates, vesting schedules, and that the positions are held as direct beneficial ownership.
What are the exercise prices of Mishor Miriam’s ICL stock options?
One ICL option grant has an exercise price of $9.39 per share, while the other is at $5.87 per share. Both U.S. dollar figures are converted from New Israeli Shekel amounts using a Bank of Israel representative exchange rate.
When do Mishor Miriam’s ICL stock options expire?
The Form 3 shows two expiration dates for the ICL options. The fully vested grant over 464,902 shares expires on February 8, 2027, and the second grant over 620,177 shares expires on April 4, 2029, defining the latest dates to exercise.
How do Mishor Miriam’s ICL stock options vest according to the Form 3?
One ICL option grant is fully vested and exercisable. The other vests in three equal annual installments starting from the April 4, 2024 grant date, meaning portions become exercisable each year over a three-year period.
Who holds legal title to Mishor Miriam’s ICL stock options?
The Form 3 notes that certain ICL stock options are held by a Trustee in Mishor Miriam’s name. Even though a Trustee holds them, the filing treats them as the reporting person’s direct beneficial ownership for SEC reporting purposes.